Week 331 Review - Optibiotix saves another poor week

Another pretty poor week for the majority of my portfolio, but OPTI:Optibiotix staged a mini rally which saved the day and clawed back £4,483 of the deficit to reduce it to £49,553. At one point the overall portfolio value dipped below £100k, but thankfully it climbed to £105,852 by the end of the week.

The gold miners had another bad week, with CEY:Centamin and PAF:Pan African Resources both dropping 5% as the gold price held below $1,800.

My new holding in SBTX:SkinBioTherapeutics did pretty badly too, dropping 6% after last week's 7% drop and re-affirming that I'm really bad at timing my purchases.

OPTI:Optibiotix climbed 3p which is 5% and almost won Share of the Week.

The Share of the Week award goes to BLU:Blue Star Capital which climbed 7% and seems to have a bit of momentum behind it. It will need a lot of momentum to claw back my 69% loss.

It looks like quite a small uptick on that chart

Still well below the trend line, but no longer the worst position of the year.

Here's the ISA and shares portfolio after week 19 of year 7.

			Weekly Change
Cash	£87.05		+£0
Portfolio cost	£72,145.21		+£0
Portfolio sell value (bid price-commission)	£49,683.59	(-31.1%)	+£2,498.90
Potential profits	£2,515.29		+£0
Yr 7 Dividends	£22.16		+£0
Yr 7 Profit from sales	£3,664.29		+£0
Yr 7 projected avg monthly profit	£842.40	(22.9%)	-£46.80
Total Dividends	£1,365.31		+£0
Total Profit from sales	£27,788.23		+£0
Average monthly cash profit	£378.08	(10.3%)	-£1.14
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	65%		+0%

A very quiet week, with JLP:Jubilee Metals flat so no change in potential profits. The big increase in value is mostly OPTI:Optibiotix, and long term performance still above 10% target.

Well it's a start, but still worse than it was 12 months ago.

Still a long way below the trend line

The SIPP looks like this after week 315 overall and week 3 of year 7.

			Weekly Change
Cash	£148.23		-£112.10
Portfolio cost	£80,392.42		+£222.45
Portfolio sell value (bid price - commission)	£54,711.75	(-31.9%)	+£2,007.15
Potential profits	£1.00		-£81.93
Yr 7 Dividends	£0		+£0
Yr 7 Interest	£0		+£0
Yr 7 Profit from sales	£381.04		+£113.35
Yr 7 projected avg monthly profit	£526.29	(12.8%)	-£17.57
Total Dividends	£3,204.39		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£24,105.67		+£113.35
Average monthly cash profit	£364.16	(8.9%)	+£0.41
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	54%		+0%

I sold my 665 WHR:Warehouse REIT shares for £113.34 (10.8%) profit because I had already qualified for the dividend and I wanted to buy more OPTI:Optibiotix while they were so cheap. I bought another 2,664 shares at 41.9898p costing £1,127.56 which brought my average SIPP price down just below 60p a share and my total OPTI holding to 174,069. I've set a target of 150,000 shares as my long term holding so hopefully the additional 24,069 will give me a little room for profit taking if they ever get into profit.

I also bought 4 more units of the iShares Physical Gold fund as part of my monthly savings plan, at 2616.854p costing £106.17.

Year 7 performance is good but I won't keep it up, and long term performance is still under target but I have nothing left to sell.

As with the ISA, there's a long way to go.

Still below the trend line, but not as bad as the ISA.

The trading account looks like this after week 281 overall and week 21 of year 6.

			Weekly Change
Cash	£259.74		+£0
Portfolio cost	£2,374.14		+£0
Portfolio sell value (bid price - commission)	£962.72	(-59.4%)	-£22.64
Potential profits	£0.00		+£0
Year 6 Dividends	£0.00		+£0
Year 6 Profit	£0.00		+£0
Yr 6 projected avg monthly profit	£0.00	(0%)	+£0
Dividends	£60.10		+£0
Profit from sales	£937.88		+£0
Average monthly cash profit	£15.39	(7.8%)	-£0.05
(Sold stocks profit + Dividends - Fees / Months)

All shares were down a few percent yet again, with DDDD:4D Pharma and HUM:Hummingbird Resources both down by 58% now, and IQE:IQE down by 71%. That's what you call a proper disaster of an account! I know my mistake was failing to sell all of them as soon as they went 15% down. I think I'm incapable of doing it, which means I'm probably incapable of trading shares. I'll keep this account going to remind me of that fact.

Ouch!

It's a spectacularly consistent trend line. Twelve months of absolute misery.

I've given up hope of any news from DDDD:4D Pharma before Christmas, and I'm getting increasingly nervous about my investment there. I may have been foolish sinking £10k into them as it's a lot to lose and I think there's still quite a bit of risk.

I think there's much less risk with OPTI:Optibiotix because of the low recurring costs, so I'm still not nervous about my investment there despite it being an insanely large percentage of my portfolio. I've had 6 years to convince myself I'm wrong, and I'm still as convinced as ever that the company is something special that doesn't come along very often. The foundations of IP and commercial bulk production are very strong, and every week we hear of more sales. Sooner or later they will tip us into profit, and that's before SweetBiotix and the microbiome modulators even get started.